Evolution of the Chronic Congestive Heart Failure Paradigm

被引:3
|
作者
Savino, John A., III [1 ]
Kosmas, Constantine E. [2 ]
Wagman, Gabriel [3 ]
Vittorio, Timothy J. [3 ]
机构
[1] Mt Sinai Sch Med, Dept Internal Med, New York, NY USA
[2] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA
[3] St Francis Hosp, Ctr Heart, Div Cardiol, Ctr Adv Cardiac Therapeut, Roslyn, NY 11576 USA
关键词
chronic congestive heart failure; cardiorenal; hemodynamic; neurohumoral; mechanical; metabolic; LEFT-VENTRICULAR FUNCTION; ACUTE MYOCARDIAL-INFARCTION; DILATED CARDIOMYOPATHY; ISOSORBIDE DINITRATE; CARDIAC-HYPERTROPHY; EXERCISE TOLERANCE; DOUBLE-BLIND; THERAPY; MORTALITY; TRIMETAZIDINE;
D O I
10.1097/CRD.0b013e318277c990
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paradigms are a part of our human nature. In the world of medicine and science, they allow investigators to work within a particular, previously accepted framework that provides certain constraints. This is the crux of Newton's quote, "If I've seen so far it's because I stood upon the shoulders of giants." However, in the same way that it allows us to build, it can constrain our thought processes if we fail to accept new data that are ill suited to an accepted paradigm. The physiological mechanisms to explain the phenomenon of chronic congestive heart failure are similar to other paradigms of science, in that they have undergone several shifts throughout their history, and continue to change with new evidence. Here, we seek to explore how our understanding of congestive heart failure has changed.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 50 条
  • [21] VASODILATORS IN CHRONIC CONGESTIVE HEART-FAILURE - REPLY
    MULROW, CD
    MULROW, JP
    AGUILAR, C
    LINN, WD
    RAMIREZ, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (17): : 2510 - 2510
  • [22] USE OF PHENTOLAMINE IN CHRONIC CONGESTIVE HEART-FAILURE
    RAMANAREDDY, CV
    GOULD, L
    ANANDARAO, N
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1979, 55 (04) : 424 - 424
  • [23] VASODILATOR THERAPY IN CHRONIC CONGESTIVE HEART-FAILURE
    SCHWARTZ, AB
    CHATTERJEE, K
    DRUGS, 1983, 26 (02) : 148 - 173
  • [24] CHRONIC THERAPY OF CONGESTIVE HEART-FAILURE WITH PRAZOSIN
    FOSTER, PR
    STEIN, L
    FRIEDMAN, AW
    MCHENRY, PL
    STATZA, J
    CLINICAL RESEARCH, 1979, 27 (02): : A166 - A166
  • [25] CARDIAC LYMPHATICS IN EXPERIMENTAL CHRONIC CONGESTIVE HEART FAILURE
    UHLEY, HN
    LEEDS, SE
    SAMPSON, JJ
    FRIEDMAN, M
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1969, 131 (02): : 379 - &
  • [26] ENDOTHELIAL FUNCTION IN CHRONIC CONGESTIVE-HEART-FAILURE
    DREXLER, H
    HAYOZ, D
    MUNZEL, T
    HORNIG, B
    JUST, H
    BRUNNER, HR
    ZELIS, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (19): : 1596 - 1601
  • [27] VASODILATOR THERAPY FOR CHRONIC CONGESTIVE HEART-FAILURE
    ABRAMS, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (21): : 3070 - 3074
  • [28] Hemostatic biomarkers in dogs with chronic congestive heart failure
    Tarnow, Inge
    Falk, Torkel
    Tidholm, Anna
    Martinussen, Torbert
    Jensen, Asger L.
    Olsen, Lisbeth H.
    Pedersen, Henrik D.
    Kristensen, Annemarie T.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (03): : 451 - 457
  • [29] VASODILATOR THERAPY IN CHRONIC CONGESTIVE HEART-FAILURE
    CHATTERJEE, K
    DEMARCO, T
    ROULEAU, JL
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (02): : A46 - A54
  • [30] Chronic Vagal Stimulation in Patients with Congestive Heart Failure
    De Ferrari, Gaetano M.
    Sanzo, Antonio
    Schwartz, Peter J.
    2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-20, 2009, : 2037 - 2039